Drug induced polymyositis secondary to leuprolide acetate (Lupron) therapy for prostate carcinoma

Clin Exp Rheumatol. 1991 Sep-Oct;9(5):525-8.

Abstract

Inflammatory myopathy has been associated with systemic inflammatory processes, endocrinopathies, malignancies and infections. Drug induced myopathies have been implicated with the use of several medications. We report a case of biopsy proven myositis whose symptoms began within 10 days of receiving leuprolide acetate therapy for prostate cancer. Drug withdrawal and brief steroid therapy resulted in clinical remission within two months of diagnosis.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Biopsy
  • Humans
  • Leuprolide / adverse effects*
  • Leuprolide / therapeutic use
  • Male
  • Microscopy, Electron
  • Muscles / pathology
  • Muscles / ultrastructure
  • Myositis / chemically induced*
  • Prostatic Neoplasms / drug therapy*

Substances

  • Leuprolide